NeoGenomics News

Increasing Losses Over Three Years Doesn't Faze NeoGenomics (NASDAQ:NEO) Investors as Stock Rises 5.3% This Past Week

If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough on longer term NeoGenomics, Inc. (NASDAQ:NEO) shareholders. Unfortunately, they

Simply Wall StMay 10 09:08 ET

NeoGenomics Earnings Analysis: Q1 Recap

The Q1 earnings report for NeoGenomics (NASDAQ:NEO) was released on Tuesday, April 30, 2024 at 07:30 AM.Here's what investors need to know about the latest announcement.EarningsNeoGenomics beat estima

BenzingaMay 10 07:21 ET

Piper Sandler Gives a Buy Rating to NeoGenomics (NEO)

TipRanksMay 6 08:28 ET

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 2 14:14 ET

NeoGenomics Is Maintained at Buy by BTIG

NeoGenomics Is Maintained at Buy by BTIG

Dow JonesMay 2 13:53 ET

Express News | BTIG Maintains Buy on NeoGenomics, Lowers Price Target to $21

BenzingaMay 2 13:43 ET

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and Envista Holdings (NVST)

TipRanksMay 2 06:40 ET

Buy Rating Affirmed for NeoGenomics Amid Strong Q1 Performance and Growth Prospects

TipRanksMay 2 02:15 ET

Express News | Neogenomics Inc : Btig Cuts Target Price to $21 From $23

ReutersMay 2 02:11 ET

NeoGenomics Is Maintained at Buy by TD Cowen

NeoGenomics Is Maintained at Buy by TD Cowen

Dow JonesMay 1 13:59 ET

Express News | TD Cowen Maintains Buy on NeoGenomics, Lowers Price Target to $20

BenzingaMay 1 13:49 ET

NeoGenomics Coverage Assumed by Craig-Hallum at Buy

NeoGenomics Coverage Assumed by Craig-Hallum at Buy

Dow JonesMay 1 13:31 ET

Express News | Craig-Hallum Assumes NeoGenomics at Buy, Announces Price Target of $26

BenzingaMay 1 13:21 ET

Express News | Benchmark Reiterates Buy on NeoGenomics, Maintains $18 Price Target

BenzingaMay 1 11:19 ET

NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

Yahoo FinanceMay 1 03:04 ET

Express News | Neogenomics Inc : TD Cowen Cuts Target Price to $20 From $21

ReutersMay 1 00:28 ET

Earnings Call Summary | NeoGenomics(NEO.US) Q1 2024 Earnings Conference

The following is a summary of the NeoGenomics, Inc. (NEO) Q1 2024 Earnings Call Transcript:Financial Performance:NeoGenomics reported Q1 revenue of $156 million, marking a 14% growth compared to the p

moomoo AIApr 30 18:18 ET · Conference Call

Where NeoGenomics Stands With Analysts

Ratings for NeoGenomics (NASDAQ:NEO) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recen

BenzingaApr 30 14:00 ET

NeoGenomics Is Maintained at Buy by Needham

NeoGenomics Is Maintained at Buy by Needham

Dow JonesApr 30 13:27 ET

NeoGenomics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 35.81% Needham $24 → $19 Maintains Buy 02/26/2024 42.96% Piper Sandler $18 → $20 Maintains Over

BenzingaApr 30 13:16 ET